UB Paderborn / Katalog / Suche / in CDI

Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis

Clinical infectious diseases, 2016-10, Vol.63 (7), p.853-867

2016

Volltextzugriff (PDF)

State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity

PloS one, 2021-04, Vol.16 (4), p.e0249012-e0249012

2021

Volltextzugriff (PDF)

The use of cephalosporins for gonorrhea: the impending problem of resistance

Expert opinion on pharmacotherapy, 2009-03, Vol.10 (4), p.555-577

2009

Volltextzugriff (PDF)

Tuberculosis Diagnostic Delays and Treatment Outcomes among Patients with COVID-19, California, USA, 2020

Emerging infectious diseases, 2024-01, Vol.30 (1), p.136-140

2024

Volltextzugriff (PDF)

Outlook for tuberculosis elimination in California: An individual-based stochastic model

PloS one, 2019-04, Vol.14 (4), p.e0214532-e0214532

2019

Volltextzugriff (PDF)

Modeling the Impact of Recommendations for Primary Care–Based Screening for Latent Tuberculosis Infection in California

Public health reports (1974), 2020-07, Vol.135 (1S), p.172S-181S

2020

Volltextzugriff (PDF)

Tuberculosis treatment managed by providers outside the Public Health Department: lessons for the Affordable Care Act

PloS one, 2014-10, Vol.9 (10), p.e110645-e110645

2014

Volltextzugriff (PDF)

Chlamydia trachomatis and Neisseria gonorrhoeae Transmission from the Oropharynx to the Urethra among Men who have Sex with Men

Clinical infectious diseases, 2009-12, Vol.49 (12), p.1793-1797

2009

Volltextzugriff (PDF)

A systematic synthesis of direct costs to treat and manage tuberculosis disease applied to California, 2015

BMC research notes, 2017-08, Vol.10 (1), p.434-434, Article 434

2017

Volltextzugriff (PDF)

Mosaic Penicillin-Binding Protein 2 in Neisseria gonorrhoeae Isolates Collected in 2008 in San Francisco, California

Antimicrobial Agents and Chemotherapy, 2009-09, Vol.53 (9), p.4032-4034

2009

Volltextzugriff (PDF)

Mainstreaming Latent Tuberculosis Infection Testing and Treatment in the United States: Who and How

JAMA internal medicine, 2017-12, Vol.177 (12), p.1764

2017

Volltextzugriff (PDF)

Tuberculosis Diagnoses Following Wildfire Smoke Exposure in California

American journal of respiratory and critical care medicine, 2023-02, Vol.207 (3), p.336-345

2023

Volltextzugriff (PDF)

High Discordance Between Pre-US and Post-US Entry Tuberculosis Test Results Among Immigrant Children: Is it Time to Adopt Interferon Gamma Release Assay for Preentry Tuberculosis Screening?

The Pediatric infectious disease journal, 2016-03, Vol.35 (3), p.231-236

2016

Volltextzugriff (PDF)

Introduction and evaluation of multidrug-resistant tuberculosis supplemental surveillance in the United States

Journal of clinical tuberculosis and other mycobacterial diseases, 2019-05, Vol.15, p.100090-100090, Article 100090

2019

Volltextzugriff (PDF)

Multistate outbreak of MDR TB identified by genotype cluster investigation

Emerging infectious diseases, 2012-01, Vol.18 (1), p.113-116

2012

Volltextzugriff (PDF)

Epidemiology, detection, and management of tuberculosis among end-stage renal disease patients

Infection control and hospital epidemiology, 2018-11, Vol.39 (11), p.1367-1374

2018

Volltextzugriff (PDF)

Re: “Prebiologic Therapy Tuberculosis Screening Experience in a Pediatric Rheumatology Center: TST and IGRA Are Both Necessary”

The Pediatric infectious disease journal, 2017-04, Vol.36 (4), p.441-441

2017

Volltextzugriff (PDF)

Risk Factors for Central Nervous System Tuberculosis

Pediatrics (Evanston), 2015-11, Vol.136 (5), p.e1276

2015

Volltextzugriff (PDF)

Impact and Effectiveness of State-Level Tuberculosis Interventions in California, Florida, New York, and Texas: A Model-Based Analysis

American journal of epidemiology, 2019-09, Vol.188 (9), p.1733-1741

2019

Volltextzugriff (PDF)

Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria

American journal of respiratory and critical care medicine, 2017-12, Vol.196 (11), p.1488-1489

2017

Volltextzugriff (PDF)

Evaluation of the Impact of a Sequencing Assay for Detection of Drug Resistance on the Clinical Management of Tuberculosis

Clinical infectious diseases, 2019-08, Vol.69 (4), p.668-675

2019

Volltextzugriff (PDF)

Epidemiology of Pediatric Multidrug-Resistant Tuberculosis in the United States, 1993–2014

Clinical infectious diseases, 2017-11, Vol.65 (9), p.1437-1443

2017

Volltextzugriff (PDF)

Increased risk of tuberculosis among foreign-born persons with diabetes in California, 2010-2012

BMC public health, 2015-03, Vol.15 (1), p.263-263, Article 263

2015

Volltextzugriff (PDF)

Traffic-Related Air Pollution and All-Cause Mortality during Tuberculosis Treatment in California

Environmental health perspectives, 2017-09, Vol.125 (9), p.097026

2017

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis

State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity

The use of cephalosporins for gonorrhea: the impending problem of resistance

Tuberculosis Diagnostic Delays and Treatment Outcomes among Patients with COVID-19, California, USA, 2020

Outlook for tuberculosis elimination in California: An individual-based stochastic model

Modeling the Impact of Recommendations for Primary Care–Based Screening for Latent Tuberculosis Infection in California

Tuberculosis treatment managed by providers outside the Public Health Department: lessons for the Affordable Care Act

Chlamydia trachomatis and Neisseria gonorrhoeae Transmission from the Oropharynx to the Urethra among Men who have Sex with Men

A systematic synthesis of direct costs to treat and manage tuberculosis disease applied to California, 2015

Mosaic Penicillin-Binding Protein 2 in Neisseria gonorrhoeae Isolates Collected in 2008 in San Francisco, California

Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis

Mainstreaming Latent Tuberculosis Infection Testing and Treatment in the United States: Who and How

Tuberculosis Diagnoses Following Wildfire Smoke Exposure in California

High Discordance Between Pre-US and Post-US Entry Tuberculosis Test Results Among Immigrant Children: Is it Time to Adopt Interferon Gamma Release Assay for Preentry Tuberculosis Screening?

Introduction and evaluation of multidrug-resistant tuberculosis supplemental surveillance in the United States

Multistate outbreak of MDR TB identified by genotype cluster investigation

Epidemiology, detection, and management of tuberculosis among end-stage renal disease patients

Re: “Prebiologic Therapy Tuberculosis Screening Experience in a Pediatric Rheumatology Center: TST and IGRA Are Both Necessary”

Risk Factors for Central Nervous System Tuberculosis

Impact and Effectiveness of State-Level Tuberculosis Interventions in California, Florida, New York, and Texas: A Model-Based Analysis

Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria

Evaluation of the Impact of a Sequencing Assay for Detection of Drug Resistance on the Clinical Management of Tuberculosis

Epidemiology of Pediatric Multidrug-Resistant Tuberculosis in the United States, 1993–2014

Increased risk of tuberculosis among foreign-born persons with diabetes in California, 2010-2012

Traffic-Related Air Pollution and All-Cause Mortality during Tuberculosis Treatment in California

Suchergebnisse filtern